Your browser doesn't support javascript.
loading
Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial).
Ananthakrishna, Rajiv; Lee, Sau L; Foote, Jonathon; Sallustio, Benedetta C; Binda, Giulia; Mangoni, Arduino A; Woodman, Richard; Semsarian, Christopher; Horowitz, John D; Selvanayagam, Joseph B.
Afiliação
  • Ananthakrishna R; College of Medicine and Public Health, Flinders University, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia; Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia.
  • Lee SL; Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia.
  • Foote J; South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Sallustio BC; Department of Clinical Pharmacology, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia; Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Australia.
  • Binda G; South Australian Health and Medical Research Institute, Adelaide, Australia; Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia.
  • Mangoni AA; Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Adelaide, Australia.
  • Woodman R; Flinders Centre for Epidemiology and Biostatistics, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Semsarian C; Agnes Ginges Centre for Molecular Cardiology, Centenary Institute and Sydney Medical School, University of Sydney, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Horowitz JD; The Queen Elizabeth Hospital, Basil Hetzel Institute for Translational Research, University of Adelaide, Adelaide, Australia.
  • Selvanayagam JB; College of Medicine and Public Health, Flinders University, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia; Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia. Electronic address: joseph.selvanayagam@flinders.edu.au.
Am Heart J ; 240: 101-113, 2021 10.
Article em En | MEDLINE | ID: mdl-34175315
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Perexilina / Fármacos Cardiovasculares / Hipertrofia Ventricular Esquerda Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Hipertrófica / Perexilina / Fármacos Cardiovasculares / Hipertrofia Ventricular Esquerda Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article